CODX · Co-Diagnostics, Inc. · Analyst Estimates
$0.26
-0.01 (-4.12%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that substantial doubt exists about the Company’s ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued. These uncertainties create substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$2.72M
Shares
10.51M
Volume · Nov 13
591.94K
Avg daily vol (3M)
1.97M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Co-Diagnostics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-14 22:44 UTC · Publication dates shown per estimate · 7 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-3.10
|
-3.10
|
-3.10
|
1
|
-13.50
|
-13.50
|
-13.50
|
-12.15
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
654,000.00
|
654,000.00
|
654,000.00
|
1
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.83
|
-0.83
|
-0.83
|
1
|
-12.00
|
-12.00
|
-12.00
|
-12.00
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
17.31M
|
17.31M
|
17.31M
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
— | — | — |
1
|
-3.30
|
-3.30
|
-3.30
|
-2.85
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
173,000.00
|
173,000.00
|
173,000.00
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
analysts
Publication date not stated |
— | — | — |
0
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1692415
CUSIP
189763204
13F (30d)
30 filings
20 filers
Visit website
Investor relations